Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 24.02%23.6B | 37.32%25.03B | 36.49%19.82B | 12.58%71.43B | 24.88%19.64B | 18.82%19.03B | 1.97%18.23B | 5.07%14.52B | 10.26%63.45B | 8.13%15.73B |
Cost of revenue | 18.81%12.66B | 37.84%13.71B | 37.40%10.94B | 11.02%39.77B | 26.82%11.2B | 24.33%10.66B | -3.66%9.95B | -1.62%7.96B | 4.34%35.82B | 2.61%8.83B |
Gross profit | 30.65%10.94B | 36.70%11.32B | 35.36%8.88B | 14.60%31.66B | 22.38%8.44B | 12.48%8.37B | 9.65%8.28B | 14.54%6.56B | 19.03%27.62B | 16.13%6.9B |
Operating expense | 8.10%5.05B | 13.41%5.03B | 10.22%4.33B | 8.82%18.05B | 7.88%5.01B | 7.88%4.67B | 11.91%4.44B | 7.79%3.93B | 4.99%16.58B | 9.27%4.64B |
Staff costs | ---- | ---- | ---- | 3.27%4.83B | ---- | ---- | ---- | ---- | 3.61%4.67B | ---- |
Selling and administrative expenses | ---- | ---- | ---- | 28.70%861M | ---- | ---- | ---- | ---- | -35.05%669M | ---- |
-Selling and marketing expense | ---- | ---- | ---- | 28.70%861M | ---- | ---- | ---- | ---- | -35.05%669M | ---- |
Research and development costs | ---- | ---- | ---- | 14.28%6.17B | ---- | ---- | ---- | ---- | 7.36%5.4B | ---- |
Other operating expenses | ---- | ---- | ---- | 5.94%6.19B | ---- | ---- | ---- | ---- | 11.79%5.84B | ---- |
Operating profit | 59.06%5.89B | 63.56%6.29B | 72.93%4.55B | 23.29%13.61B | 52.24%3.43B | 18.86%3.71B | 7.16%3.85B | 26.38%2.63B | 48.94%11.04B | 33.39%2.25B |
Net non-operating interest income (expenses) | -140.00%-2M | -75.00%1M | 33.33%4M | 233.33%10M | 71.43%-2M | 150.00%5M | 0.00%4M | -25.00%3M | -62.50%3M | -800.00%-7M |
Non-operating interest income | 25.00%25M | -10.53%17M | 35.71%19M | 85.37%76M | 76.92%23M | 81.82%20M | 90.00%19M | 100.00%14M | 57.69%41M | 85.71%13M |
Non-operating interest expense | 80.00%27M | 6.67%16M | 36.36%15M | 73.68%66M | 25.00%25M | 66.67%15M | 150.00%15M | 266.67%11M | 111.11%38M | 233.33%20M |
Net investment income | -48.74%-177M | -102.82%-10M | 102.91%3M | -79.07%63M | 41.53%-69M | -150.42%-119M | 81.54%354M | -758.33%-103M | 784.09%301M | -107.02%-118M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -193.75%-47M | -50.00%-9M | -44.44%-13M | 38.46%-80M | 18.33%-49M | 62.79%-16M | 72.73%-6M | -80.00%-9M | 27.37%-130M | -15.38%-60M |
Less:Other special charges | 193.75%47M | 50.00%9M | 44.44%13M | -38.46%80M | -18.33%49M | -62.79%16M | -72.73%6M | 80.00%9M | 94.03%130M | 36.36%60M |
Other non-operating income (expenses) | 6.25%51M | -18.81%82M | -18.84%56M | 31.91%372M | 69.23%154M | -34.25%48M | 55.38%101M | 30.19%69M | 25.33%282M | 49.18%91M |
Income before tax | 57.81%5.72B | 47.75%6.36B | 77.60%4.6B | 21.54%13.97B | 60.34%3.46B | 7.03%3.62B | 12.24%4.3B | 22.07%2.59B | 54.97%11.5B | 31.54%2.16B |
Income tax | 53.26%1.53B | 25.89%1.66B | 419.92%1.25B | 0.45%3.16B | -4.60%601M | -11.61%997M | 33.57%1.32B | -39.60%241M | 40.13%3.15B | 16.88%630M |
Net income | 59.50%4.19B | 57.41%4.69B | 42.48%3.34B | 29.49%10.81B | 87.03%2.86B | 16.34%2.63B | 4.85%2.98B | 36.37%2.35B | 61.42%8.35B | 38.69%1.53B |
Net income continuous operations | 59.54%4.19B | 57.43%4.69B | 42.46%3.35B | 29.49%10.81B | 87.16%2.86B | 16.34%2.63B | 4.82%2.98B | 36.35%2.35B | 61.42%8.35B | 38.73%1.53B |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 59.50%4.19B | 57.41%4.69B | 42.48%3.34B | 29.49%10.81B | 87.03%2.86B | 16.34%2.63B | 4.85%2.98B | 36.37%2.35B | 61.42%8.35B | 38.69%1.53B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 59.50%4.19B | 57.41%4.69B | 42.48%3.34B | 29.49%10.81B | 87.03%2.86B | 16.34%2.63B | 4.85%2.98B | 36.37%2.35B | 61.42%8.35B | 38.69%1.53B |
Gross dividend payment | ||||||||||
Basic earnings per share | 61.88%101.65 | 59.47%113.72 | 43.09%80.4 | 29.27%258.56 | 86.85%68.265 | 16.21%62.795 | 4.63%71.31 | 36.09%56.19 | 61.21%200.015 | 38.39%36.535 |
Diluted earnings per share | 61.88%101.65 | 59.47%113.72 | 43.09%80.4 | 29.27%258.56 | 86.85%68.265 | 16.21%62.795 | 4.63%71.31 | 36.09%56.19 | 61.21%200.015 | 38.39%36.535 |
Dividend per share | 0 | 100.00%35 | 0 | 47.83%85 | 58.82%67.5 | 0 | 16.67%17.5 | 0 | 40.24%57.5 | 49.12%42.5 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |